Also trades as: NXGLW (NASDAQ) · $vol 0M
NXGL NASDAQ
NEXGEL, Inc.
1W: +0.0%
1M: -49.9%
3M: -67.8%
YTD: -90.4%
1Y: -92.8%
3Y: -91.1%
$0.17
-0.00 (-2.52%)
Weekly Expected Move ±18.4%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships0
As Filer
counterparties named
4
As Counterparty
mentioned by others
2023-12-05
Earliest Filing
2026-03-10
Latest Filing
Mentioned As Counterparty
4 mentionsOther companies that named NXGL in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| CELUW Celularity Inc | licensee | Licensee acquiring assets and receiving exclusive license | 2026-03-10 | View |
| NXGLW NEXGEL, INC. | licensee | Licensee acquiring assets and receiving exclusive license | 2026-03-10 | View |
| NXGLW NEXGEL, INC. | target | Buyer purchasing eyeliner and lash business assets | 2024-05-20 | View |
| NXGLW NEXGEL, INC. | target | Buyer purchasing assets of Kenkoderm skincare line | 2023-12-05 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR